Stilboestrol and adenocarcinoma of the vagina. Statement by the Australian Drug Evaluation Committee.
出版信息
Med J Aust. 1972 Sep 9;2(11):622-3.
PMID:5082789
Abstract
摘要
相似文献
1
Stilboestrol and adenocarcinoma of the vagina. Statement by the Australian Drug Evaluation Committee.
Med J Aust. 1972 Sep 9;2(11):622-3.
2
Stilboestrol and cancer.己烯雌酚与癌症
Br Med J. 1971 Sep 11;3(5775):593-4.
3
Editorial: Prenatal exposure to stilboestrol.
Med J Aust. 1975 Mar 22;1(12):373-4.
4
[Vaginal adenocarcinoma as a late result of treatment of threatened abortion with diethylstilbestrol].[己烯雌酚治疗先兆流产导致的晚期阴道腺癌]
Cesk Gynekol. 1973 Jul;38(6):473-4.
5
Stilbestrol and vaginal cancer.己烯雌酚与阴道癌
Am J Nurs. 1974 May;74(5):900-1.
6
Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
Wis Med J. 1972 Feb;71(2):87-93.
7
[Vaginal adenomatesis and adenocarcinoma in young women after diethylstilbestrol treatment].[己烯雌酚治疗后年轻女性的阴道腺瘤样增生和腺癌]
Rev Med Liege. 1974 Nov 15;29(22):682-7.
8
[Teratogenic effect of diethylstilbestrol during pregnancy; the extent of the DES problem in the Netherlands].
Ned Tijdschr Geneeskd. 1982 Jul 24;126(30):1350-8.
9
10
Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.孕期使用己烯雌酚治疗后出现的阴道腺病、发育异常及透明细胞腺癌。
Obstet Gynecol. 1974 May;43(5):645-52.
Zotero 插件